TCL Archive Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds September 26, 2003
TCL Archive Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial July 25, 2014